Header

And Industry Research Reports

First Name:
Email:
 
 

GLGT NEWS | GLGT | Forum

 
You must be logged in to post Login Register


Register? | Lost Your Password?

Search Forums:


 






Minimum search word length is 4 characters – Maximum search word length is 84 characters
Wildcard Usage:
*  matches any number of characters    %  matches exactly one character

No Tags
UserPost

6:21 pm
September 20, 2011


Ted Liverman

Guest

Henderson, Nevada, September 20, 2011 – - Global General Technologies Inc. (GLGT;www.glgt-corporate.com)  is providing this update to its shareholders and followers. Following the merger of AB (Wuhan) Biotech with Global General Technologies Inc. in April 2011, the management of the China-based company has been expressing frustration with the current low share price and by the constant stream of direct enquiries from the GLGT shareholders about the China company well being and legitimacy of China operations.
Jim Qian President of AB (Wuhan) Biotech said "We adopted a non dilution policy. Since signing the agreement merger with GLGT about 6 months ago, we have spent a lot of energy and time on this initiative.  After a board meeting, our company has recently made a decision to withdraw from GLGT and go back to being a private company.  We need to focus on our operations in the private domain, as the constant stream of direct enquiries from the GLGT shareholders, and slanderous Internet postings  has taken its toll on us.  
We wish to part ways amicably with GLGT. We have been in touch with the preferred shareholders and other majority stake holders. Plans are well underway to find alternative interim management and a suitable merger candidate to replace AB (Wuhan) Biotech.
Upon the announcement of the definitive agreement of AB (Wuhan) Biotech diversification all stock received in the merger will be returned to GLGT treasury.  AB (Wuhan) Biotech kindly requests GLGT shareholders to make all inquiries directly to GLGT  board directly corporate@glgt-corporate.com and not to the operating subsidiary AB (Wuhan) Biotech during this transition stage.
In other company news, the company intends to commence a reverse split. A name change is planed for GLGT once a suitable merger candidate is located to replace AB (Wuhan) Biotech. Moreover, GLGT management is using this opportunity to advise its followers that the China Solar manufacturing company is no longer an option which the company is exploring.
GLGT  interim management will keep its followers advised on a timely basis.

No Tags

About the Stocks We Like Forum

Forum Timezone: UTC 0

Most Users Ever Online: 46

Currently Online:
12 Guests

Currently Browsing this Topic:
1 Guest

Forum Stats:

Groups: 1
Forums: 119
Topics: 13248
Posts: 53790

Membership:

There are 788 Members
There have been 103 Guests

There are 3 Admins

Top Posters:

no name – 4209
morganagordona – 3911
ottogrunf – 3194
Judith Keenan – 2502
stock.angele – 2352
stevenvalmont – 1550

Recent New Members: 0815-trader, Thomas Last, Mark Cafel, James Miller, Milly Joel, Benny Cole

Administrators: Admin (49 Posts), stockswe (1 Post), Editor (0 Posts)



 

Latest Investor News


Loading...
  •